![Laura Mondano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laura Mondano
Nessuna posizione attualmente
Profilo
Laura Mondano worked as a Director of Global Regulatory Affairs at Genzyme Corp.
and as a Manager of Regulatory Affairs at both Boston Scientific Corp.
and Anika Therapeutics, Inc. She then served as the Vice President of Regulatory and Quality at Histogenics Corp.
from 2012 to 2016, and as the Vice President of Regulatory Affairs at Harvard Apparatus Regenerative Technology, Inc. Ms. Mondano received her undergraduate degree from the University of New Hampshire.
Precedenti posizioni note di Laura Mondano
Società | Posizione | Fine |
---|---|---|
OCUGEN, INC. | Consigliere Generale | 01/02/2016 |
ANIKA THERAPEUTICS, INC. | Consigliere Generale | - |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Consigliere Generale | - |
BOSTON SCIENTIFIC CORPORATION | Consigliere Generale | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Consigliere Generale | - |
Formazione di Laura Mondano
University of New Hampshire | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
ANIKA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Histogenics Corp.
![]() Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Laura Mondano